Transplant Diagnostics Market Growth 2019: Competitive Analysis like Thermo Fisher Scientific, F. Hoffman-La Roche Limited, QIAGEN, Immucor, Illumina, BD, Caredx, Sigma-Aldrich Corporation, Abbott

Global Transplant Diagnostics Market By Technology (Molecular Assay Technologies (PCR-Based Molecular Assay Technologies (Real-Time PCR, SSP-PCR, SSO-PCR), Sequencing-Based Molecular Assay Technologies (Sanger, NGS)), Non-Molecular Assay Technologies), Product type (Reagents & Consumables, Instruments, Software & Services), Application (Diagnostic, Research), Products & Services (Reagents and Consumables, Instruments, Software and Services), End User (Hospitals & Transplant Centers, Commercial Service Providers, Research Laboratories and Academic Institutes), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Global Transplant Diagnostics Market is expected to rise from its initial estimated value of USD 2.54 billion in 2018 to an estimated value of USD 5.18 billion by 2026, registering a CAGR of 9.3% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing rising incidence of chronic and infectious diseases.

FREE | Get a Copy of Sample Report Now @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-transplant-diagnostics-market

Key Market Competitors:

Few of the major competitors currently working in the transplant diagnostics market are Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Limited(Switzerland), QIAGEN ( Germany), Biomérieux S.A. (France), Immucor, Inc.(US) , Illumina, Inc. (US), BD(US), Caredx, Inc.(US), Gendx (The Netherlands), Sigma-Aldrich Corporation (US), Abbott (US) , DiaSorin S.P.A. (Italy), Affymetrix, Inc. (US), Omixon Ltd (Hungary ). Olerup SSp AB (Sweden), Linkage Biosciences (US), Admera Health (US), New York Blood Center (US), The Sequencing Center (US), and others

Market Definition: Global Transplant Diagnostics Market

Transplant diagnostics are the diagnostics tests performed while relocating organ in order to treat organ failure such as liver, pancreas, lungs, kidney, and heart. These tests are widely performed by skilled and trained professionals in hospitals & transplant centers, commercial service providers, research laboratories and academic institutes.

According to World Health Organization, there were an estimated 9.6 million deaths in 2018 due to cancer; Cancer is the second leading cause of death globally. About 1 in 6 deaths is due to cancer. These deaths could have been avoided with the availability of proper medical equipment and devices for healthcare procedures. This significant number is expected to act as a driver to the market growth

Market Drivers

• Increasing number of pre-term births taking place globally which requires increased concern and focus on the infants born boosting the growth of the market

• Increased number of children deaths and healthcare associated infections in infants is also expected to act as a driver to the market growth

• There is rise in incidence of chronic and infectious diseases is expected to act as a driver to the market growth

• There is rise in number of transplantation procedures is also expected to act as a driver to the market growth

Market Restraints

• High amount of costing of performing HLA matching using PCR and NGS devices is expected to act as a restraint to the market growth

• Adoption & preference of refurbished medical equipment and devices in the developing regions is also expected to restrain the market growth

Segmentation: Global Transplant Diagnostics Market

By Technology

• Molecular Assay Technologies

o PCR-Based Molecular Assay Technologies

 Real-Time PCR
 SSP-PCR
 SSO-PCR

o Sequencing-Based Molecular Assay Technologies

 Sanger
 NGS

• Non-Molecular Assay Technologies

o Serological Assays
o Mixed Lymphocyte Culture (MLC) Assays

By Product type

• Reagents & Consumables
• Instruments
• Software
• Services

By Application

• Diagnostic
• Research

Products & Services

• Reagents and Consumables
• Instruments
• Software and Services

By End User

• Hospitals
• Transplant Centers
• Commercial Service Providers
• Research Laboratories
• Academic Institutes

By Geography

• North America

• South America

• Europe

• Asia-Pacific

• Middle East & Africa

FREE | Request For TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-transplant-diagnostics-market

Key Developments in the Market:

• In April 2019, CareDx acquired OTTR. OTTR provides comprehensive solutions for transplant patient management. Focus of this is to simplify the logistics of ordering AlloSure or AlloMap testing for patients.

• In Jul 2017, Thermo Fisher Scientific Acquires Linkage Bio. Linkage develops and markets molecular diagnostic technologies for complex genetic testing. Focus of this acquisition is to innovate, and expanded support globally.

Competitive Analysis:

Global transplant diagnostics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of transplant diagnostics market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

• Current and future of global transplant diagnostics market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
• Regions/Countries that are expected to witness the fastest growth rates during the forecast period

• The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

• All segmentation provided above in this report is represented at country level

• All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Inquiry Before Buying @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-transplant-diagnostics-market

About Us:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.